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but surprising increase in the count of epididymo-deferential
spermatozoa (P == 0.09) which could be related to a secretion
or absorption defect of the luminal fluid.
Conclusion: These preliminary results suggested a testicular
and genital toxicity of BBP and p,p' -DDE in mice exposed in
utero, as was previously shown in rat. Our results indicated
also a toxic effect of both xenohormones in mice exposed
during puberty, notably a deleterious effect on the DNA of
germ cells for BBP. However, increasing the number of
experiments is warranted to confirm all the toxic effects
observed.
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0-155. Insulin-like growth factor-II (IGF-II) mediates the
steroidogenic and growth-promoting actions of follicle-
stimulating hormone on human ovarian pre-antral
follicles cultured in vitro
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University School of Medicine, Stanford, CA 94305-5317,
USA
FSH is important for ovarian antral follicle growth and
steroidogenesis, processes in the human that are believed to
be mediated by IGF-II. The objective of this study was to
determine if human ovarian pre-antral follicles are also FSH and
IGF-II responsive, since the clinical questions and mechanisms
underlying the effects on the pre-antral follicle pool of exogen-
ously administered gonadotrophins for fertility therapy and
elevated endogenous gonadotrophins in the peri-menopause
remain unanswered.
Class 2 pre-antral follicles were isolated from human pre-
menopausal ovaries (n == 6)" and cultured in vitro with
androstenedione and either no additives or with FSH or IGF-
II. FSH (100 ng/ml) stimulated oestradiol production by
3.58 ± 0.4-fold over 48 h, compared to controls without FSH.
This effect was completely inhibited in the presence of the
IGF-II antagonist, IGF binding protein-4 (IGFBP-4). IGF-II
also stimulated oestradiol production by pre-antral follicles
with doses as low as 1 ng/ml and within 24 h of treatment.
Maximal response of three- to ninefold above control was
achieved with 100 ng/ml of IGF-II between 96 and 120 h of
culture. IGFBP-4 completely inhibited oestradiol production
to basal levels. FSH stimulated IGF-II mRNA in pre-antral
follicles about fourfold, determined by RT-PCR. FSH also
stimulated follicle growth, determined by light microscopy,
86
50-68% over 48 h, compared to controls (P < 0.001), a
process that was inhibited in the presence of IGFBP-4.
Cumulatively, these data demonstrate that FSH and IGF-
II stimulate pre-antral follicle oestradiol production, FSH
stimulates pre-antral follicle growth and IGF-II rnRNA expres-
sion, and IGFBP4 inhibits FSH and IGF-II effects on the pre-
antral follicle, supporting IGF-II as a mediator of FSH action
on human pre-antral follicles.
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Introduction: Ovarian tissue can be collected and cryopre-
served for women at risk of losing ovarian function. Studies
in animals show that frozen-thawed ovarian tissue can restore
fertility when surgically returned to the donor, or other histoc-
ompatible recipient. Follicle survival within a graft will depend
on the graft site. Pieces grafted to well-vascularized sites, such
as the kidney, exhibit high survival rates, while grafts to sites
such as the abdominal wall have fewer surviving follicles. It
is thought that this effect depends on the rate of vascular
ingrowth into the graft. Vascular endothelial growth factor
(VEGF) is a very potent angiogenic factor. VEGF mRNA
levels increase significantly in grafted ovarian tissue and
ovaries of mice and rats treated with gonadotrophins. This
study examined the hypothesis that the administration of
exogenous gonadotrophins will influence follicular survival in
ovarian tissue pieces transplanted to sub-optimal sites.
Materials and methods: Immature inbred Balb/C mice were
used as donors and recipients. The hormonal treatment regimen
comprised twice daily intraperitoneal (i.p.) injections of recom-
binant human follicle stimulating hormone (3 IV rhFSH,
Gonal-F; Serono, Switzerland) and luteinizing hormone (3 IV
rhLH, Lhadi; Serono, Switzerland). At surgery recipients were
bilaterally ovariectomized and then had a whole ovary inserted
into each of two subperitoneal pockets. Six days after surgery
all mice were administered 10 IV pregnant mare serum
gonadotrophin (Intervet, Australia) i.p to induce follicular
maturation, i.e. to test the functional capacity of the transplanted
tissue. Seven days after surgery all the grafted ovaries were
collected and processed for serial sections, staining and count-
ing of all growing follicles. Six groups were investigated:
controls without stimulation (group i); females given a 4 day
course of rhFSH + rhLH starting before (ii), during (iii) or
after (iv) insertion of normal ovaries (to examine recipient
effects) and normal females receiving ovaries from mice
treated with rhFSH + rhLH for either 2 (v) or 4 (vi) days
before collection (to examine donor effects).
Results: Compared to the non-stimulated control group the
number of growing follicles per ovary increased significantly
(P < 0.005, analysis of variance) in recipients administered
rhFSH + rhLH before and after grafting (group iii), but not
if the stimulation stopped or started (groups ii and iv) at the
time of surgery. Ovaries collected from donors stimulated for
2 days before collection (group V) showed a tendency to an
increased number of growing follicles. If the stimulation
lasted 4 days (group vi), the increase was highly significant
(P = 0.007).
Conclusion: The administration of rhFSH/rhLH can improve
the viability of grafted ovarian tissue.
Acknowledgement: This project was funded by Serono
(Australia).
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Introduction: In an attempt to overcome developmental arrest
of early embryos cultured in media alone, various co-culture
systems have been developed including Vero cells. We have
previously demonstrated that embryos co-cultured with Vero
cells display enhanced development in vitro and this could be
due to an interaction between the embryo and cellular layer
mediated by paracrine cytokine (IL-1 ~). In addition, we have
recently shown that both gonadotrophin releasing hormone
(GnRH) and its receptor are expressed at the mRNA and
protein level in vivo by human endometrium throughout the
entire menstrual cycle. Moreover, we have also demonstrated
that preimplantation embryos (mouse and human) also express
this hormone and its receptor, suggesting that GnRH may also
playa role in the embryonic/endometrial dialogue during early
implantation. Thus, we postulated that Vero cell monolayer
used in embryo co-culture may provide an environment similar
to endometrial cavity; the embryotrophic effect may be due to
paracrine regulation of GnRH by co-cultured cells. Therefore,
we assessed GnRH and its receptor mRNA and protein
expression in Vero cell monolayer.
Materials and methods: Viable Vero cells (1X lOS/well) were
cultured in multiple-well tissue culture plates before the
introduction of embryos and 4-well chamber slides for immuno-
histochemical study containing Dulbecco's modified Eagle's
medium (DMEM) with 5% fetal bovine serum. Confluent cell
monolayer was then cultured in medium containing human
tubal fluid and DMEM in 1:1 ratio until use. Total RNA
extracted from Vero cells was reverse transcribed into eDNA
and amplified by polymerase chain reaction (PCR) using
specific primers for GnRH target eDNA (399 bp). The expres-
sion of GnRH receptor (231 bp) was amplified by two-round
nested PCR. To determine the presence of GnRH at the protein
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level in Vero cell monolayer, cells were fixed in chamber
slides until processed for immunohistochemical staining using
avidin-biotin alkaline phosphatase method. Human luteal phase
endometrium was used as a positive control. Deletion of the
primary antibody was used as a negative control.
Results: The GnRH and GnRH receptor mRNA were both
amplified in Vero cells by PCR. Immunoreactive GnRH at the
protein level was present with intense staining in Vero cells
monolayer according to avidin-biotin alkaline phosphatase
method.
Conclusions: Our results suggest that Vero cell GnRH expres-
sion at the mRNA and protein level may play a substantial
role in early embryo/epithelial dialogue during embryo co-
culture, suggesting the embryotrophic effect may be due to
expression of GnRH by co-cultured cells.
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Introduction: The incidence of reproductive abnormalities in
humans is increasing: falling sperm counts and rising rates of
testicular cancer, hypospadias and cryptorchidism. These
effects may be attributable to in-utero exposure to endocrine-
disrupting chemicals (EDC). We previously described an in-
vitro culture system in which the EDC dieldrin inhibits the
gonadotrophin-stimulated testosterone and inhibin B secretion
[Brown E. et al. (1998) J. Reprod. Fertil., Abstract Ser., 21,
55]. Rodent studies have shown that in-utero exposure to EDC
affects specific genes in the developing gonad, such as the
steroidogenic enzyme cytochrome P450 17a-hydroxylase/CI7-
20-lyase (P450c17) [Majdic G. et al. (1996) Endocrinology,
137, 1063-1070]. The androgen receptor (AR) is also thought
to be an important target for EDC. We have investigated the
expression of these EDC-sensitive genes in 13, 15 and 18-19
week human fetal testis, and we present some preliminary data
from an ongoing study.
Materials and methods: Human fetal testes, collected at 13
weeks (n = 2), 15 weeks (n = 1) and 18-19 weeks (n = 2)
gestation (spanning the period of Leydig cell hyperplasia),
were either fixed immediately in Bouin's for 5.5 h or cut into
explants and cultured in Dulbecco's modified Eagle's medium!
Ham's F12 with 10% human male serum for periods of 2, 8
and 24 h. Bouin-fixed cultured and control tissues were paraffin
embedded for (i) morphological analysis by haematoxylin and
eosin staining, (ii) immunolocalization of P450c 17 and (iii)
immunolocalization of the AR. Immunostaining was by stand-
ard avidin-biotin-peroxidase detection.
Results: P450c 17 was localized to the testicular interstitial
area at all gestational stages examined. In line with increased
numbers of Leydig cells, P450c 17 immunostaining was more
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